Skip to content

Effectiveness of opioid-sparing and opioid-free anesthesia in daytime hysteroscopic surgery without intubation of general anesthesia

Effectiveness of opioid-sparing and opioid-free anesthesia in daytime hysteroscopic surgery without intubation of general anesthesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099316
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Traditional anesthesia group:Induction: propofol 2 mg/kg, alfentanil 10 µg/kg, maintenance: intravenous infusion of propofol 4-8 mg/(kg-h), alfentanil 0.2-1 mg/(kg-h). Intraoperative anesthesiologists
Opioid-sparing anesthesia group:Induction: propofol 2 mg/kg, esketamine 0.2 mg/kg, alfentanil 5 µg/kg, Maintenance: intravenous infusion of propofol 4-8 mg/(kg-h), alfentanil 0.2-1 mg/(kg-h). Intraope
Opioid-free anesthesia group:Flurbiprofen ester 50 mg and dexamethasone 5 mg were given in advance. induction: propofol 2 mg/kg, esketamine, and lidocaine 1.5 mg/kg. maintenance: intravenous infusion

Sponsors

The First Affiliated Hospital,Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Eligible subjects were between the ages of 18 and 70 years old, scheduled for painless hysteroscopic surgery at the First Affiliated Hospital of Zhejiang University School of Medicine, and had an American Society of Anesthesiologists (ASA) physical status of Class I-III.

Exclusion criteria

Exclusion criteria: Relevant to the subject: Hearing impaired unable to communicate; subjects with mental or neurological disorders. Lesion-Related: Subjects with clinically significant preoperative cardiovascular disease. Subjects in a pregnant state. Exclusion Criteria Related to Comorbid Medications Subjects with preoperative chronic pain or taking pain medication prior to surgery.

Design outcomes

Primary

MeasureTime frame
Intraoperative drug dosage;Number of times respiratory support was required intraoperatively;Postoperative pain visual analog score;Postoperative recovery room stay;

Secondary

MeasureTime frame
Postoperative subject satisfaction;Number of intraoperative body movements;Number of intraoperative body movements;

Countries

China

Contacts

Public ContactShuhan Gu

The First Affiliated Hospital,Zhejiang University School of Medicine

shuhangu@foxmail.com+86 135 1581 3047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026